Observational Study of Functional Outcomes After Chemoradiotherapy for Squamous Cell Cancer of the Anus
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Anal Cancer
Both
Anal Cancer
Trial Information
Observational Study of Functional Outcomes After Chemoradiotherapy for Squamous Cell Cancer of the Anus
Inclusion Criteria:
- Participant is willing and able to give informed consent for participation in the
study.
- Male or Female, aged 18 years or above.
- Squamous cell or basaloid carcinoma of the anal canal
Exclusion Criteria:
- adenocarcinoma, melanoma, lymphoma, sarcoma or other malignancy of anal canal
- Any synchronous or metanchronous pelvic malignancy of non-anal origin (eg. prostatic,
genital tract)
- unable to complete questionnaire
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Functional quality of life after chemoradiotherapy for anal cancer
Outcome Description:
Quality of life measured using: General EORTC (European Organisation for Research and Treatment of Cancer) QLQ-C30 Disease specific EORTC QLQ-CR29 Vaizey incontinence score MOS (Medical Outcomes Survey) sexual questionnaire
Outcome Time Frame:
3 years
Safety Issue:
No
Authority:
United Kingdom: Research Ethics Committee
Study ID:
A092896
NCT ID:
NCT01853059
Start Date:
October 2013
Completion Date:
October 2017
Related Keywords:
- Anal Cancer
- Anal cancer
- Squamous cell cancer
- Radiotherapy
- Chemoradiotherapy
- Conformational radiotherapy
- Intensity modulated radiation therapy
- IMRT
- Anus Neoplasms
- Carcinoma, Squamous Cell
- Neoplasms, Squamous Cell
Name | Location |
|---|
